{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T16:01:54Z","timestamp":1772121714369,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Veterinary Immunology and Immunopathology"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.vetimm.2008.09.027","type":"journal-article","created":{"date-parts":[[2008,10,14]],"date-time":"2008-10-14T21:54:43Z","timestamp":1224021283000},"page":"114-124","source":"Crossref","is-referenced-by-count":10,"title":["Generation and characterization of novel canine malignant mast cell line CL1"],"prefix":"10.1016","volume":"127","author":[{"given":"Tzu-Yin","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachael","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Chien","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Breen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl A.","family":"London","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vetimm.2008.09.027_bib1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev.med.55.091902.103822","article-title":"Systemic mastocytosis","volume":"55","author":"Akin","year":"2004","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.vetimm.2008.09.027_bib2","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.bbrc.2007.12.053","article-title":"Establishment of a novel high-affinity IgE receptor-positive canine mast cell line with wild-type c-kit receptors","volume":"366","author":"Amagai","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.vetimm.2008.09.027_bib3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0165-2427(01)00428-7","article-title":"IgE enhances Fc epsilon RI expression and IgE-dependent TNF-alpha release from canine skin mast cells","volume":"85","author":"Brazis","year":"2002","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetimm.2008.09.027_bib4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0165-2427(00)00188-4","article-title":"Stem cell factor enhances IgE-mediated histamine and TNF-alpha release from dispersed canine cutaneous mast cells","volume":"75","author":"Brazis","year":"2000","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetimm.2008.09.027_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1471-2164-5-65","article-title":"An integrated 4249 marker FISH\/RH map of the canine genome","volume":"5","author":"Breen","year":"2004","journal-title":"BMC Genomics"},{"key":"10.1016\/j.vetimm.2008.09.027_bib6","first-page":"309","article-title":"Canine and feline neoplasia","volume":"14","author":"Brodey","year":"1970","journal-title":"Adv. Vet. Sci. Comp. Med."},{"key":"10.1016\/j.vetimm.2008.09.027_bib7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.iac.2006.05.006","article-title":"Systemic mastocytosis: clinical manifestations and differential diagnosis","volume":"26","author":"Butterfield","year":"2006","journal-title":"Immunol. Allergy Clin. North Am."},{"key":"10.1016\/j.vetimm.2008.09.027_bib8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1165\/ajrcmb\/3.5.413","article-title":"Establishment of two dog mastocytoma cell lines in continuous culture","volume":"3","author":"DeVinney","year":"1990","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.vetimm.2008.09.027_bib9","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.2460\/ajvr.2002.63.1718","article-title":"Prevalence and importance of internal tandem duplications in exons 11 and 12 of c-kit in mast cell tumors of dogs","volume":"63","author":"Downing","year":"2002","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.vetimm.2008.09.027_bib10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/cncr.21996","article-title":"Imatinib mesylate in the treatment of systemic mastocytosis: a phase II trial","volume":"107","author":"Droogendijk","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.vetimm.2008.09.027_bib11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1155\/1998\/341340","article-title":"Immunophenotypic characterization of human bone marrow mast cells A flow cytometric study of normal and pathological bone marrow samples","volume":"16","author":"Escribano","year":"1998","journal-title":"Anal. Cell Pathol."},{"key":"10.1016\/j.vetimm.2008.09.027_bib12","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1182\/blood-2003-07-2477","article-title":"17-Allylamino-17-demethoxygeldanamycin (17-AAG) is effective in down-regulating mutated, constitutively activated KIT protein in human mast cells","volume":"103","author":"Fumo","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.vetimm.2008.09.027_bib13","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1172\/JCI116761","article-title":"Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand independent activation of c-kit product","volume":"92","author":"Furitsu","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vetimm.2008.09.027_bib14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0165-2427(97)00166-9","article-title":"Comparative morphofunctional study of dispersed mature canine cutaneous mast cells and BR cells, a poorly differentiated mast cell line from a dog subcutaneous mastocytoma","volume":"62","author":"Garcia","year":"1998","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetimm.2008.09.027_bib15","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.exphem.2007.06.005","article-title":"Synergistic antiproliferative effects of KIT tyrosine kinase inhibitors on neoplastic canine mast cells","volume":"35","author":"Gleixner","year":"2007","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.vetimm.2008.09.027_bib16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.imlet.2004.12.001","article-title":"Differential gene expression profile between cord blood progenitor-derived and adult progenitor-derived human mast cells","volume":"98","author":"Inomata","year":"2005","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.vetimm.2008.09.027_bib17","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1093\/bioinformatics\/bth355","article-title":"Breakpoint identification and smoothing of array comparative genomic hybridization data","volume":"20","author":"Jong","year":"2004","journal-title":"Bioinformatics"},{"key":"10.1016\/j.vetimm.2008.09.027_bib18","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.leukres.2007.04.003","article-title":"A novel canine lymphoma cell line: a translational and comparative model for lymphoma research","volume":"31","author":"Kisseberth","year":"2007","journal-title":"Leuk. Res."},{"key":"10.1016\/j.vetimm.2008.09.027_bib19","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1158\/0008-5472.CAN-07-0426","article-title":"Myc goes global: new tricks for an old oncogene","volume":"67","author":"Knoepfler","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.vetimm.2008.09.027_bib20","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1158\/1541-7786.MCR-08-0067","article-title":"Gain-of-function mutations in the extracellular domain of KIT are common in canine mast cell tumors","volume":"6","author":"Letard","year":"2008","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.vetimm.2008.09.027_bib21","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1182\/blood-2001-12-0350","article-title":"Inhibition of constitutively active forms of mutant kit by multitargeted indolinone tyrosine kinase inhibitors","volume":"100","author":"Liao","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.vetimm.2008.09.027_bib22","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.exphem.2008.05.001","article-title":"The novel HSP90 inhibitor STA-9090 exhibits activity against Kit-dependent and -independent malignant mast cell tumors","volume":"136","author":"Lin","year":"2008","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.vetimm.2008.09.027_bib23","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.vetimm.2006.09.001","article-title":"A functional comparison of canine and murine bone marrow derived cultured mast cells","volume":"114","author":"Lin","year":"2006","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetimm.2008.09.027_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.vetimm.2006.03.024","article-title":"Generation and characterization of bone marrow-derived cultured canine mast cells","volume":"113","author":"Lin","year":"2006","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetimm.2008.09.027_bib25","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nature04338","article-title":"Genome sequence, comparative analysis and haplotype structure of the domestic dog","volume":"438","author":"Lindblad-Toh","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.vetimm.2008.09.027_bib26","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0301-472X(98)00075-7","article-title":"Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit","volume":"27","author":"London","year":"1999","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.vetimm.2008.09.027_bib27","first-page":"2755","article-title":"Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs wtih spontaneous malignancies","volume":"9","author":"London","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.vetimm.2008.09.027_bib28","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0195-5616(03)00003-2","article-title":"Mast cell tumors in the dog","volume":"33","author":"London","year":"2003","journal-title":"Vet. Clin. North Am. Small Anim. Pract."},{"key":"10.1016\/j.vetimm.2008.09.027_bib29","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1073\/pnas.96.4.1609","article-title":"Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis","volume":"96","author":"Longley","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.vetimm.2008.09.027_bib30","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0889-8588(05)70302-6","article-title":"New approaches to therapy for mastocytosis A case for treatment with kit kinase inhibitors","volume":"14","author":"Longley","year":"2000","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.vetimm.2008.09.027_bib31","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0145-2126(01)00028-5","article-title":"Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy","volume":"25","author":"Longley","year":"2001","journal-title":"Leuk. Res."},{"key":"10.1016\/j.vetimm.2008.09.027_bib32","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1523-1747.1999.00488.x","article-title":"Clustering of activating mutations in c-KIT's juxtamembrane coding region of canine mast cell neoplasms","volume":"112","author":"Ma","year":"1999","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.vetimm.2008.09.027_bib33","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1182\/blood.V99.5.1741","article-title":"The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations","volume":"99","author":"Ma","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.vetimm.2008.09.027_bib34","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nrc1393","article-title":"Analysis of genomic targets reveals complex functions of MYC","volume":"4","author":"Patel","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.vetimm.2008.09.027_bib35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1172\/JCI115853","article-title":"Dog mastocytoma cells produce transforming growth factor beta 1","volume":"90","author":"Pennington","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vetimm.2008.09.027_bib36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1582-4934.2002.tb00183.x","article-title":"Chromosome-mediated alterations of the MYC gene in human cancer","volume":"6","author":"Popescu","year":"2002","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.vetimm.2008.09.027_bib37","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.bbrc.2005.09.150","article-title":"Structure and regulation of Kit protein-tyrosine kinase\u2014the stem cell factor receptor","volume":"338","author":"Roskoski","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.vetimm.2008.09.027_bib38","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000080659","article-title":"Canine mast cell activation via human IgG1 and IgG4","volume":"135","author":"Sato","year":"2004","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.vetimm.2008.09.027_bib39","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1182\/blood-2005-10-3969","article-title":"Dasatinib (BMS-354825) inhibits KITD816V, an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis","volume":"108","author":"Shah","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.vetimm.2008.09.027_bib40","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000053820","article-title":"IgG-mediated histamine release from canine mastocytoma-derived cells","volume":"125","author":"Takahashi","year":"2001","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.vetimm.2008.09.027_bib41","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1038\/sj.bjc.6601275","article-title":"Chromosome aberrations in canine multicentric lymphomas detected with comparative genomic hybridisation and a panel of single locus probes","volume":"89","author":"Thomas","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.vetimm.2008.09.027_bib42","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/jhered\/esm053","article-title":"A cytogenetically characterized, genome-anchored 10-Mb BAC set and CGH array for the domestic dog","volume":"98","author":"Thomas","year":"2007","journal-title":"J. Hered."},{"key":"10.1016\/j.vetimm.2008.09.027_bib43","unstructured":"Thomas, R., Duke, S.E., Karlsson, E.K., Evans, A., Ellis, P., Lindblad-Toh, K., Langford, C.F., Breen, M., in press, A genome assembly-integrated dog 1Mb BAC microarray: a cytogenetic resource for canine cancer studies and comparative genomic analysis. Cytogenet Genome Res."},{"key":"10.1016\/j.vetimm.2008.09.027_bib44","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/10428190400010775","article-title":"Mastocytosis: pathology, genetics, and current options for therapy","volume":"46","author":"Valent","year":"2005","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.vetimm.2008.09.027_bib45","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.1523-1747.2000.00827.x","article-title":"Mast cell and myeloid marker expression during early in vitro mast cell differentiation from human peripheral blood mononuclear cells","volume":"114","author":"Welker","year":"2000","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.vetimm.2008.09.027_bib46","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cancergencyto.2006.03.015","article-title":"Polysomy 13 in a canine prostate carcinoma underlining its significance in the development of prostate cancer","volume":"169","author":"Winkler","year":"2006","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.vetimm.2008.09.027_bib47","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1354\/vp.39-5-529","article-title":"Mutations in the juxtamembrane domain of c-KIT are associated with higher grade mast cell tumors in dogs","volume":"39","author":"Zemke","year":"2002","journal-title":"Vet. Pathol."}],"container-title":["Veterinary Immunology and Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165242708003723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165242708003723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T23:52:05Z","timestamp":1545695525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165242708003723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":47,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0165242708003723"],"URL":"https:\/\/doi.org\/10.1016\/j.vetimm.2008.09.027","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1163321.625025","asserted-by":"object"}]},"ISSN":["0165-2427"],"issn-type":[{"value":"0165-2427","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}